Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...
  • 4/22/2025AZ's Ultomiris for Generalized Myasthenia Gravis in China
  • 4/22/2025China Approves New Indication of Opdivo for NSCLC
  • 4/22/2025Kelun-Biotech's ADC SKB518 Wins U.S. FDA IND Clearance
  • 4/22/2025Ensem Thera Advances China-Linked Oncology Program with U.S. FDA IND C...
  • 4/22/2025Zai Lab's Repotrectinib sNDA Accepted by China NMPA
  • 4/22/2025Hengrui Initiates Phase I Trial for Novel Obesity siRNA Drug HRS-5817 ...
  • 4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...
  • 4/19/2025China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...
  • 4/19/2025HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials
  • 4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
  • 4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...
  • 4/17/2025Eli Lilly's Mirikizumab Advances in China with New Indication Filing
  • 4/17/2025InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...
  • 4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
  • 4/15/2025Akeso Initiates First Clinical Trial for AK139, Its First Non-Oncology...
  • 4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
  • 4/15/2025Gardasil9 Gains Expanded Approval in China
  • 4/14/2025Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...
  • 4/14/2025Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
  • 4/11/2025Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...
  • 4/11/2025China Greenlights First Gene Therapy for Hemophilia B
  • 4/10/2025XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...
  • 4/10/2025Novartis Files for New Indication of Long-Acting Cholesterol-Lowering ...
  • 4/10/2025Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...
  • 4/10/2025ArkBio Completes Phase 3 Trial for AK0901 for ADHD in China 
  • 4/9/2025RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG
  • 4/9/2025China Launches Phase I Trial for Nation's First Monkeypox Vaccine
  • 4/8/2025Akeso Initiates Investigator-Initiated Trial for Personalized mRNA Vac...
  • 4/5/2025Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
  • Page:4/14 Total number of articles:409: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group